Equity · Healthcare
PGNY
NASDAQProgyny (PGNY)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for PGNY to draw a line in its place.
as of Jul 17, 2026
Progyny (PGNY) insider trades
In the 90 days to 23 Oct 2026, Progyny insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 13 Nov 2025.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Progyny (PGNY) reported financials
SEC EDGARProgyny reported revenue of $1.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $58.5M.
Progyny (PGNY) earnings
Progyny last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.34; no next date is announced in SEC filings yet.
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
Progyny (PGNY) institutional holders (13F)
SEC EDGAR10 of the 45 institutional funds we track reported a Progyny position for the quarter ended 30 Jun 2026 — a combined $115.7M; the latest of those filings landed 02 Sep 2026.
Progyny (PGNY) fails-to-deliver
SECOn 28 Sep 2026, 670 shares of Progyny failed to deliver (about $17K).
Congressional trades in Progyny (PGNY)
House disclosuresThe most recent congressional trade disclosed in Progyny is a sale by Josh Gottheimer (house, NJ), dated 06 Dec 2024.
Progyny (PGNY): frequently asked questions
Have Progyny insiders bought or sold shares recently?
In the 90 days to 23 Oct 2026, Progyny insiders reported 3 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 13 Nov 2025. A further 11 filings were grants, awards, gifts or exercises rather than open-market trades.
How many institutions hold Progyny?
10 of the 45 institutional funds we track reported a Progyny position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.
Has Progyny had fails-to-deliver recently?
Yes. The most recent SEC fails-to-deliver record for Progyny is dated 28 Sep 2026, when 670 shares failed to deliver.
When did Progyny last report earnings?
Progyny last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.34; no next date is announced in SEC filings yet.
What exchange is Progyny listed on?
Progyny trades on NASDAQ under the ticker PGNY.
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
Sources
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
- SEC EDGARSEC EDGAR 13F filings
- SECSEC fails-to-deliver (CNS) data
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARValuation computed from SEC EDGAR filings